Prognosis and Treatment of Follicular Lymphoma
Considerations surrounding the use of the FLIPI2 and PRIMA-PI scoring systems for risk assessment of patients with high-risk follicular lymphoma, and making decisions for treatment initiation versus a watch-and-wait approach.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Видео Prognosis and Treatment of Follicular Lymphoma канала Targeted Oncology
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Видео Prognosis and Treatment of Follicular Lymphoma канала Targeted Oncology
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Dr. Darren Feldman on the Drawbacks of Dose Intensification for Advanced Germ Cell Tumors](https://i.ytimg.com/vi/dDlDgIBV_bM/default.jpg)
![Dr. Melnick on EZH2 as a Potential Target in Diffuse Large B Cell Lymphoma](https://i.ytimg.com/vi/Eb0TbnB234s/default.jpg)
![Pembrolizumab Therapy for Microsatellite Instability-High Colorectal Cancer](https://i.ytimg.com/vi/jq5WPUXMJkA/default.jpg)
![Emerging Targeted Therapies in Marginal Zone Lymphoma](https://i.ytimg.com/vi/zwsGE59Z6PQ/default.jpg)
![Selecting EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Lung Cancer](https://i.ytimg.com/vi/L14h0hLzre8/default.jpg)
![Inadequately Controlled Polycythemia Vera](https://i.ytimg.com/vi/bQJ1q4F52tw/default.jpg)
![Results for Tisotumab Vedotin in Patients With Metastatic or Recurrent Cervical Cancer](https://i.ytimg.com/vi/VmrZgsljPxo/default.jpg)
![Cabazitaxel Improves rPFS in Patients with mCRPC](https://i.ytimg.com/vi/HsxnV-YxhgQ/default.jpg)
![CD19 and CD20 Antibodies in Development](https://i.ytimg.com/vi/2ez3cZ5dt3E/default.jpg)
![David Berz, MD, PhD, and Philip Bonomi, MD Discuss Liquid Biopsies Versus Tissue Biopsies](https://i.ytimg.com/vi/RLK4KQpr0Cc/default.jpg)
![Advanced Non-Melanoma Skin Cancer: PD-1–Targeted Therapy](https://i.ytimg.com/vi/-4Qqz8IonQA/default.jpg)
![Polycythemia Vera: JAK2 Inhibitor Patient Selection](https://i.ytimg.com/vi/bijmjYwiHnA/default.jpg)
![Exploring Potential HER2-Positive Breast Cancer Treatments for the Future](https://i.ytimg.com/vi/Rxfeh4yP1U4/default.jpg)
![An Early-Stage Trial of Immunotherapy for Advanced Sarcomas](https://i.ytimg.com/vi/yyZffpH0SQE/default.jpg)
![Phase III CASSIOPEIA Impacts Treatment Decisions in Patients With Multiple Myeloma](https://i.ytimg.com/vi/tWiYdwg5c4g/default.jpg)
![Results for Maintenance Olaparib in BRCA-Mutated Platinum-Sensitive Ovarian Cancer](https://i.ytimg.com/vi/44HWFJU041s/default.jpg)
![Analyzing Responses to 177LuPSMA-617 in Patients With Metastatic CRPC](https://i.ytimg.com/vi/xBEY0OBn93o/default.jpg)
![Antibody Drug Conjugate Sacituzumab Govitecan Shows Efficacy in TNBC](https://i.ytimg.com/vi/JRb8PMIDZfs/default.jpg)
![Exploring Intratumoral Immunotherapy in Melanoma and Other Malignancies](https://i.ytimg.com/vi/AU5_Frdd_-E/default.jpg)
![Targeted Agents Evolve in Anaplastic, Medullary Thyroid Cancer Treatment Paradigms](https://i.ytimg.com/vi/qjlr-FBjXGw/default.jpg)
![Laboratory Monitoring for Polycythemia Vera](https://i.ytimg.com/vi/VmEcfm9zPRw/default.jpg)